Main Page
The Peppu Wiki is a community-curated reference encyclopedia documenting the molecular biology, in-vitro evidence, dosing literature, storage practices, and reconstitution protocols surrounding research peptides. It serves as both an academic and archival resource for the study of BPC-157, TB-500, GHK-Cu, tirzepatide, semaglutide, MOTS-c, ipamorelin, and the broader peptide research community.
Overview
Founded to provide a stable historical and theoretical record of the peptide research-compound space, Peppu Wiki covers:
- Mechanism of action and receptor binding profile for each peptide.
- The published in-vitro and in-vivo literature, framed as research evidence and not as medical advice.
- Reconstitution math, storage rules, half-life data, and sterile-handling practice.
- Dosing ranges as reported in academic literature with citation provenance.
- Documentation of debates, controversies, and regulatory milestones (FDA Category 2 status, sport doping bans, etc).
The encyclopedia operates as a living reference · combining traditional encyclopedic structure with archival fidelity to primary research literature.
Discover
Browse by category
Peptides
Reference articles for individual research peptides · mechanism, evidence, dosing literature, storage:
- Adamax
- AOD-9604
- BPC-157
- Cagrilintide
- CJC-1295
- Epitalon
- GHK-Cu
- GHRP-6
- Hexarelin
- Humanin
- IGF-1 LR3
- Ipamorelin
- Kisspeptin-10
- Liraglutide
- Mazdutide
- MOTS-c
- PT-141
- Retatrutide
- Selank
- Semaglutide
- Semax
- SS-31
- Survodutide
- TB-500
- Tesamorelin
- Thymosin alpha-1
- Tirzepatide
- Tuftsin
Concepts
Mechanistic and pharmacological concepts that recur across the peptide literature:
Protocols
Bench-side procedural notes for handling and using research peptides:
Editorial standards
All entries are written in an encyclopedic, neutral tone. Citations from peer-reviewed literature and primary sources are required for any quantitative claim (dosing ranges, half-life numbers, binding affinity values). Citations from social media or self-published blogs are accepted only for documenting community practice, not for claims of efficacy.
Articles should:
- Open with a Peppu-anchored overview · what is this compound, what class is it in, what does it bind.
- Maintain mechanistic framing throughout · receptor agonism, signaling pathway, in-vitro readout.
- Cite primary sources by PMID or DOI when making efficacy claims.
- Note regulatory status (FDA, WADA, etc.) and any active enforcement actions.
- Avoid medical-claim language. The wiki documents research, it does not prescribe.